Oxbow Advisors LLC Buys 4,060 Shares of Healthpeak Properties, Inc. (NYSE:DOC)

Oxbow Advisors LLC grew its stake in Healthpeak Properties, Inc. (NYSE:DOC) by 1.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 379,016 shares of the real estate investment trust’s stock after purchasing an additional 4,060 shares during the period. Healthpeak Properties makes up about 0.9% of Oxbow Advisors LLC’s portfolio, making the stock its 27th biggest position. Oxbow Advisors LLC’s holdings in Healthpeak Properties were worth $7,683,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also modified their holdings of the company. HM Payson & Co. bought a new stake in shares of Healthpeak Properties in the 3rd quarter valued at approximately $25,000. S.A. Mason LLC bought a new stake in shares of Healthpeak Properties in the 3rd quarter valued at approximately $26,000. Fortitude Family Office LLC bought a new stake in shares of Healthpeak Properties in the 3rd quarter valued at approximately $32,000. Barrett & Company Inc. bought a new stake in shares of Healthpeak Properties in the 3rd quarter valued at approximately $33,000. Finally, Avior Wealth Management LLC bought a new stake in shares of Healthpeak Properties in the 3rd quarter valued at approximately $37,000. 93.57% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on the company. Morgan Stanley raised Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price target for the company in a research note on Wednesday, January 15th. StockNews.com lowered Healthpeak Properties from a “hold” rating to a “sell” rating in a research note on Wednesday, October 30th. Royal Bank of Canada raised their price target on Healthpeak Properties from $25.00 to $26.00 and gave the stock an “outperform” rating in a research note on Monday, November 4th. Wells Fargo & Company decreased their price target on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 10th. Finally, Robert W. Baird decreased their price target on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a research note on Tuesday, February 11th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $24.00.

Healthpeak Properties Trading Down 0.1 %

DOC opened at $19.75 on Friday. The stock’s fifty day moving average is $20.20 and its two-hundred day moving average is $21.39. The company has a market capitalization of $13.81 billion, a P/E ratio of 56.42, a PEG ratio of 2.14 and a beta of 1.15. Healthpeak Properties, Inc. has a 52 week low of $16.01 and a 52 week high of $23.26. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96.

Healthpeak Properties Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 26th. Shareholders of record on Friday, February 14th will be issued a dividend of $0.305 per share. This is an increase from Healthpeak Properties’s previous quarterly dividend of $0.30. This represents a $1.22 annualized dividend and a yield of 6.18%. The ex-dividend date of this dividend is Friday, February 14th. Healthpeak Properties’s dividend payout ratio (DPR) is presently 348.58%.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.